Apr 01 Maine Cancer Genomics Initiative (MCGI) Forum

About

The Maine Cancer Genomics Initiative (MCGI), an alliance of Maine oncology providers, led by The Jackson Laboratory (JAX), is pleased to present its 5th annual MCGI Forum in a hybrid in-person and virtual format. The goal of the forum is to bring together the Maine oncology community and provide insights about the impact of precision oncology. Join us for this two-day event as we focus on access to and interpretability of precision medicine treatment options for the Maine oncology community.

We are "Building Bridges Through Genomic Medicine." During the 2022 Forum we will feature several key areas of precision oncology. The MCGI team aims to build the bridge between new translational research developments and clinical application. We have an exciting line-up of educational presentations from a number of high-profile speakers to be announced. .

In-person attendance at the Samoset in Rockport, ME is open to members of the Maine oncology community. Virtual attendance is open to all. We look forward to having you join us for this event. Click here to register for virtual attendance. Maine oncology community members will receive an email invitation to attend in-person.

COVID Attestation Forms for In-Person Attendees

All in-person attendees must fill out the following forms to attend the event. Paper copies of these forms will be available at the event check-in desk at the Samoset. Anyone who cannot complete these forms or has a positive test result will be asked to attend the MCGI Forum virtually.

Non-employee Attestation
& Consent Form

Coronavirus (COVID-19)
Arrival Testing Compliance

Certified Continuing Education

Click the button below for information regarding certified continuing education, how to claim credits, and conflict of interest disclosures.

Continuing Education

Registration

MCGI Forum Registration

The Virtual MCGI Forum will bring together the oncology community in Maine and beyond and provide the opportunity to reflect on the successes of MCGI to date and to share insights about the broader impacts of precision oncology.

MCGI ForumPast Event

2022 MCGI Forum

About

COVID Attestation Forms for In-Person Attendees

Certified Continuing Education

Schedule

Registration

MCGI Forum Registration

People

Eric Anderson, Ph.D.

MaineHealth Institute for Research

Ramya Antony, F.N.P., M.S.N., B.S.N., B.S.

FDA

Kimberly Blackwell, M.D.

Tempus

Jennifer Bourne, M.S.

The Jackson Laboratory

Erin Bradshaw

Patient Advocate Foundation

Jessica Cary, M.S., R.N., CGC

New England Cancer Specialists

Dipanjan Chowdhury, Ph.D.

Dana-Farber Cancer Institute

Alanna J. Church, M.Sc., M.D., FRCPC

Boston Children's Hospital

Khanh Do, M.D.

Moderna Therapeutics

Steven G. DuBois, M.D., M.S.

Dana-Farber Cancer Institute

Emily Edelman, M.S., CGC

The Jackson Laboratory

Matthew Frigault, M.D.

Massachusetts General Hospital

Lory Gaitor, B.S., CCRC

The Jackson Laboratory

Leah Graham, Ph.D.

The Jackson Laboratory

Petra Helbig, CCRP

The Jackson Laboratory

Ching Lau, M.D., Ph.D.

The Jackson Laboratory

Lindsey Kelley, M.P.H., M.S., CGC

The Jackson Laboratory

Jill Kolesar, Pharm.D.

University of Kentucky

Coleman Lindsley, M.D., Ph.D.

Dana-Farber Cancer Institute

Lincoln D. Nadauld, M.D., Ph.D.

Intermountain Healthcare

Andrew Norden, M.D., M.P.H., M.B.A.

OncoHealth

Peter J. O'Dwyer, M.D.

Penn Medicine

Gregory Omerza, Ph.D., M.B.(ASCP)

The Jackson Laboratory

Kate Reed, M.P.H., Sc.M., CGC

The Jackson Laboratory

Jens Rueter, M.D.

The Jackson Laboratory

Richard Schilsky, M.D.

University of Chicago

Stephanie Sharp, M.S., CGC

Maine Medical Center

Sarah Sinclair, D.O.

Northern Light Cancer Care

Michael Snyder, Ph.D.

Stanford Center for Genomics and Personalized Medicine

Christian Thomas, M.D., FASCO

New England Cancer Specialists

David Thomas, FRACP, Ph.D.

University of New South Wales

Jennifer Trowbridge, Ph.D.

The Jackson Laboratory

Christine Walko, Pharm.D.

Moffitt Cancer Center